Citigroup's significant increase in TSMC's target price to NT $950 and strong demand for AI are expected to drive performance
芊芊551
发表于 2024-4-10 21:24:31
204
0
0
Citigroup's significant increase in TSMC's target price to NT $950, driven by strong AI demand, is expected to boost performance. Citigroup stated in a report that driven by strong AI demand, it is expected that TSMC's revenue in the second quarter will increase by 4% quarter on quarter, and gross profit margin may slightly decline due to the impact of the earthquake. The target price will be raised by 28% to NT $950.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Strong collaboration! TikTok and Amazon have reached a cooperation agreement. The former claims to provide a seamless shopping experience
- Citibank raises South African economic growth forecast for 2024
- The Shanghai Regulatory Bureau of the State Financial Supervision Administration has approved the appointment qualification of Huang Xiaowei from Citibank
- Institutions report strong iPhone 16 series panel shipments in July
- Q2 performance growth is strong, and the stock price of Yaduo Group has risen by 13.32%
- Chip transmission is a heavyweight! The global semiconductor market is experiencing a strong recovery
- Citigroup Financial Holding and others establish Zhigu Holdings in Zhejiang with a registered capital of 1 billion yuan
- OpenAI's senior management changes have sparked heated discussions. CFO claims that the company's strong position remains unshaken
- Institution: iPhone 16 Pro models continue to maintain strong demand in the third week
- See you in court in December! Arm and Qualcomm are calling out to each other through aerial communication for authorization and licensing
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 昨天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 5 小时前
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 6 小时前
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 8 小时前
- 支持
- 反对
- 回复
- 收藏